Genomics
Number of studies: 2
Cohort size: 85
Unique patient: 55
Specimen type: Fresh Frozen Tissue, Blood - Plasma and Buffy coat
Transcriptomics
Number of studies: 1
Cohort size: 10
Unique patient: 10
Specimen type: Blood - Buffy coat
Proteomics
Number of studies: 6
Cohort size: 320
Unique patient: 172
Specimen type: Urine, Blood - Plasma and Serum
Other
Number of studies: 7
Cohort size: 122
Unique patient: 113
Specimen type: FFPE Tissue, Blood - Plasma, Serum and Buffy coat
PCRFTB Publication Catalog
| PMID | Title | PI | Year |
|---|---|---|---|
| 38556877 | Prognostication for recurrence patterns after curative resection for pancreatic ductal adenocarcinoma | Prof Hemant Kocher | 2024 |
| 36942939 | Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion | Prof Richard Grose | 2023 |
| 38035115 | Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion | Prof Hemant Kocher | 2023 |
| 36535941 | Genomic heterogeneity in pancreatic cancer organoids and its stability with culture (EGAD00001009741) | Dr Jerome Irianto | 2022 |
| 36612275 | Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control Study | Prof Hemant Kocher | 2022 |
| 35392854 | Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer (EGAD00001008593) | Prof Claude Chelala | 2022 |
| 33076134 | Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine | Prof Tatjana Crnogorac-Jurcevic | 2021 |
| 34188166 | Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma | Prof Hemant Kocher | 2021 |
| 33479048 | CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma | Prof John Marshall | 2021 |
| 34252585 | Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice | Prof Hemant Kocher | 2021 |
| 32211672 | Urine metallomics signature as an indicator of pancreatic cancer | Prof Tatjana Crnogorac-Jurcevic | 2020 |
| 31857725 | Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients | Prof Tatjana Crnogorac-Jurcevic | 2020 |
| 33301466 | A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study | Prof Tatjana Crnogorac-Jurcevic | 2020 |
| 32919211 | Development of a simple, sensitive and selective colorimetric aptasensor for the detection of cancer-derived exosomes | Prof Khuloud Al-Jamal | 2020 |
| 32973176 | Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer | Prof Hemant Kocher | 2020 |
| 33381282 | Validation of a Novel, Flash-Freezing Method: Aluminum Platform | Prof Hemant Kocher | 2020 |
| 30121627 | Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma | Prof Christopher Heeschen | 2019 |
| 29129714 | Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine | Prof Tatjana Crnogorac-Jurcevic | 2018 |
| 29059374 | The Pancreatic Expression Database: 2018 update | Prof Claude Chelala | 2017 |
| 27541064 | Pancreatic cancer tissue banks: where are we heading? | Prof Hemant Kocher | 2016 |